ArticleScientific reports2025

Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma.

Maryam Soleimani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.